FDA Inspection 1210240 — Loyola University Chicago Health Sciences Campus IRB
The FDA completed an inspection of Loyola University Chicago Health Sciences Campus IRB on June 23, 2023 in Maywood, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 23, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Maywood, IL (United States)
Additional Details
IRB